相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。N-linked sugar-regulated protein folding and quality control in the ER
Abla Tannous et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Pitfalls in le neuroimaging of glioblastoma in le era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response
Raymond Y. Huang et al.
FRONTIERS IN NEUROLOGY (2015)
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
Fred Fack et al.
ACTA NEUROPATHOLOGICA (2015)
Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma
Morgane Sanzey et al.
PLOS ONE (2015)
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
Katharina Bluemlein et al.
Oncotarget (2015)
Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes
Daniel Stieber et al.
ACTA NEUROPATHOLOGICA (2014)
Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies
Olivier Keunen et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility
Andrew J. Percy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)
Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects
Tracy T. Batchelor et al.
CLINICAL CANCER RESEARCH (2014)
Current status of antiangiogenic therapies for glioblastomas
Isabel Arrillaga-Romany et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Towards developing biomarkers for glioblastoma multiforme: a proteomics view
Savita Jayaram et al.
EXPERT REVIEW OF PROTEOMICS (2014)
Pyruvate kinase M2 and cancer: an updated assessment
Mohd Askandar Iqbal et al.
FEBS LETTERS (2014)
Quantitative Proteomic Analysis Reveals Effects of Epidermal Growth Factor Receptor (EGFR) on Invasion-promoting Proteins Secreted by Glioblastoma Cells
Vineet Sangar et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma
Emeline Tabouret et al.
NEURO-ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pregabalin versus Pramipexole for Restless Legs Syndrome
Ion Anghelescu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Peptide Manager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species
Kevin Demeure et al.
FRONTIERS IN GENETICS (2014)
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
Anna Golebiewska et al.
BRAIN (2013)
Comparative Proteomics of Glioma Stem Cells and Differentiated Tumor Cells Identifies S100A9 as a Potential Therapeutic Target
Song Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
METHOD OF THE YEAR Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry
Michael A. Gillette et al.
NATURE METHODS (2013)
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson et al.
NEURO-ONCOLOGY (2013)
Gene Set Based Integrated Data Analysis Reveals Phenotypic Differences in a Brain Cancer Model
Kjell Petersen et al.
PLOS ONE (2013)
Temozolomide-modulated glioma proteome: Role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity
Durairaj M. Kumar et al.
PROTEOMICS (2013)
Targeted proteomics strategy applied to biomarker evaluation
Yeoun Jin Kim et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Comparative and Quantitative Global Proteomics Approaches: An Overview
Barbara Deracinois et al.
PROTEOMES (2013)
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Karl H. Plate et al.
ACTA NEUROPATHOLOGICA (2012)
Protein Folding Drives Disulfide Formation
Pallav Kosuri et al.
CELL (2012)
A Xenograft Mouse Model Coupled with In-depth Plasma Proteome Analysis Facilitates Identification of Novel Serum Biomarkers for Human Ovarian Cancer
Hsin-Yao Tang et al.
JOURNAL OF PROTEOME RESEARCH (2012)
LC-MS/MS Analysis of Differentially Expressed Glioblastoma Membrane Proteome Reveals Altered Calcium Signaling and Other Protein Groups of Regulatory Functions
Ravindra Varma Polisetty et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Dimitrios Anastasiou et al.
NATURE CHEMICAL BIOLOGY (2012)
Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis
Poonam Gautam et al.
PLOS ONE (2012)
Investigation of serum proteome alterations in human glioblastoma multiforme
Kishore Gollapalli et al.
PROTEOMICS (2012)
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Sybille Mazurek
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Selected reaction monitoring applied to proteomics
Sebastien Gallien et al.
JOURNAL OF MASS SPECTROMETRY (2011)
Targeted mass spectrometry approaches for protein biomarker verification
Zhaojing Meng et al.
JOURNAL OF PROTEOMICS (2011)
Proteomics for identifying mechanisms and biomarkers of drug resistance in cancer
Xin-Hui Li et al.
JOURNAL OF PROTEOMICS (2011)
A targeted proteomics-based pipeline for verification of biomarkers in plasma
Jeffrey R. Whiteaker et al.
NATURE BIOTECHNOLOGY (2011)
Malectin Participates in a Backup Glycoprotein Quality Control Pathway in the Mammalian ER
Carmela Galli et al.
PLOS ONE (2011)
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Olivier Keunen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach
Brigitte Collet et al.
PROTEOME SCIENCE (2011)
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review
Paolo E. Porporato et al.
FRONTIERS IN PHARMACOLOGY (2011)
Options and considerations when selecting a quantitative proteomics strategy
Bruno Domon et al.
NATURE BIOTECHNOLOGY (2010)
A reproducible brain tumour model established from human glioblastoma biopsies
Jian Wang et al.
BMC CANCER (2009)
iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
Uros Rajcevic et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Malectin:: A novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation
Thomas Schallus et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Selected reaction monitoring for quantitative proteomics: a tutorial
Vinzenz Lange et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
The PeptideAtlas project
Frank Desiere et al.
NUCLEIC ACIDS RESEARCH (2006)
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors
RL Zhang et al.
GLIA (2003)
分享论文
